Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...

Moderna (MRNA) is scheduled to announce Q3 earnings results on November 6, before market open, with analysts’ consensus pointing to another quarter of losses. Analysts have projected a loss of -$2.16 ...

The health impact of a Covid infection was higher than the risks from the vaccine for teens and children - but it won't ...

Moderna (MRNA) just began dosing patients in a Phase 1/2 study of mRNA-2808, its experimental T-cell therapy for advanced multiple myeloma. This effort highlights Moderna's growing emphasis on cancer ...

Q3 2025 Earnings Call Transcript November 3, 2025 BioNTech SE misses on earnings expectations. Reported EPS is $-0.14 EPS, expectations were $0.75. Operator: Welcome to BioNTech’s Third Quarter 2025 ...

The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...

Veracyte, Inc. , a leading genomic diagnostics company, today announced the publication of two studies demonstrating the Afirma GRID (Genomic Resource for Intelligent Discovery) research tool's ...

Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting ...

I know how destructive unchecked addiction can be. All the victims of the ongoing opioid crisis do, too. And this is about ...

The reference to “genetic material” may lead to misconceptions, but mRNA does not enter the cell nucleus, where our DNA ...

A stunning new study offers early evidence that Covid-19 vaccines might have a secret superpower: a precisely timed mRNA shot ...